INVESTOR
RELATIONS
INVESTOR
RELATIONS
2024.04.11
Timely Disclosure
Start of Joint Research about Public Transportation Diversity and Health
2024.04.09
Timely Disclosure
Launch of Disease/Injury and Drug Use Statistics Dashboard Service Using Medical Big Data
2024.03.29
Timely Disclosure
Notice of Executive Appointments
2024.03.29
Timely Disclosure
Notice of Change in Representative Directors of the Subsidiary
2024.03.29
Timely Disclosure
Notice of Settlement of Accounts of Parent Company, etc.
2024.02.13
Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year Ending March 31, 2024 (Nine Months Ended December 31, 2023)
2023.11.10
Summary of Consolidated Financial Results for the Second Quarter of Fiscal Year Ending March 31, 2024 (Six Months Ended September 30, 2023)
2023.08.10
Summary of Consolidated Financial Results for the First Quarter of Fiscal Year Ending March 31, 2024 (Three Months Ended June 30, 2023)